Title: Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
Journal: Journal of medicinal chemistry 20120223
1135210-68-2 | 4-(Butylamino)-1-ethyl-6-methyl1H-pyrazolo[3,4b]pyridine-5-ethylcarboxylatehydrochloride | AA01ENO5 | MFCD03791317
1639417-54-1 | Tenalisib R Enantiomer | AA01ENWP | MFCD31657421
1450824-22-2 | Td 139 | AA01EO2K | MFCD29919388
2137030-98-7 | Ensartinib hydrochloride | AA01EO5X | MFCD31657344
1644545-52-7 | Vorasidenib | AA01EOBQ | MFCD31630835
1673534-76-3 | PD-1-IN-1 | AA01EOGZ | MFCD30738000
1977495-97-8 | Trilaciclib hydrochloride | AA01EON8 | MFCD31630829
1869954-38-0 | [1-(2,2-dimethylpropyl)-1H-indol-3-yl]-2-naphthalenyl-methanone | AA01EOU9
1883548-87-5 | 3-cyclohexyl-6-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]-2,4(1H,3H)-pyrimidinedione | AA01EP2P
1383539-73-8 | 4-cyclopentyl-2-[[(2,5-dimethylphenyl)methyl]thio]-1,6-dihydro-6-oxo-5-pyrimidinecarbonitrile | AA01EPCG | MFCD27966183